Novavax, Inc.
VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY
Last updated:
Abstract:
Disclosed herein are nanoparticles suitable for use in vaccines. The nanoparticles present antigens from pathogens surrounded to and associated with a detergent core resulting in enhanced stability and good immunogenicity. Dosages, formulations, and methods for preparing the vaccines and nanoparticles are also disclosed.
Status:
Application
Type:
Utility
Filling date:
20 Aug 2019
Issue date:
2 Apr 2020